Odyssean, LLC

CIK 0002092853 · DARIEN, CT · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Odyssean, LLC reported 485 positions worth $614.9M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: RARE (0.7%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$614.9M
2026 Q2
Positions
485
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
6.0%
Est. Net Flow (Q)
2026 Q2
10 / 485 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1RAREULTRAGENYX PHARMACEUTICAL INSH$4.1M0.66%122,087
2KYMRKYMERA THERAPEUTICS INCSH$4.0M0.64%34,485
3IDYAIDEAYA BIOSCIENCES INCSH$3.8M0.62%102,582
4PCVXVAXCYTE INCSH$3.6M0.59%62,638
5AFRMAFFIRM HLDGS INCSH$3.6M0.58%43,968
6CLDXCELLDEX THERAPEUTICS INC NEWSH$3.5M0.58%95,069
7LOARLOAR HOLDINGS INCSH$3.5M0.57%43,660
8MIRMMIRUM PHARMACEUTICALS INCSH$3.5M0.57%29,924
9DASHDOORDASH INCSH$3.5M0.57%18,915
10KRYSKRYSTAL BIOTECH INCSH$3.5M0.57%9,349

The free plan shows the top 10 positions. The remaining 475 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Odyssean, LLC hold as of Q2 2026?

Odyssean, LLC reported 485 positions worth $614.9M in its Q2 2026 13F filing. Largest positions: RARE (0.7%), KYMR (0.6%), IDYA (0.6%), PCVX (0.6%) and AFRM (0.6%).

What did Odyssean, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Odyssean, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.